Gilead Gets European CHMP's Positive Opinion On Its Type II Variation Application For Truvada
July 22, 2016 at 12:38 PM EDT
Gilead Sciences, Inc. (NASDAQ: GILD) revealed Friday that the Committee for Medicinal Products for Human Use (CHMP), the European ...